ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $134,000 | -25.1% | 102,100 | +0.4% | 0.00% | – |
Q4 2021 | $179,000 | -26.6% | 101,700 | -9.4% | 0.00% | – |
Q3 2021 | $244,000 | -43.5% | 112,300 | -9.1% | 0.00% | – |
Q2 2021 | $432,000 | -56.3% | 123,500 | +23.1% | 0.00% | – |
Q1 2021 | $989,000 | -9.0% | 100,300 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $1,087,000 | +5.2% | 100,300 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,033,000 | -51.7% | 100,300 | -2.1% | 0.00% | 0.0% |
Q2 2020 | $2,138,000 | +232.0% | 102,400 | +55.4% | 0.00% | – |
Q1 2020 | $644,000 | +3.4% | 65,900 | +21.8% | 0.00% | – |
Q4 2019 | $623,000 | +111.2% | 54,100 | 0.0% | 0.00% | – |
Q3 2019 | $295,000 | -54.1% | 54,100 | 0.0% | 0.00% | – |
Q2 2019 | $643,000 | +506.6% | 54,100 | +166.5% | 0.00% | – |
Q1 2019 | $106,000 | +96.3% | 20,300 | +18.0% | 0.00% | – |
Q4 2018 | $54,000 | -48.1% | 17,200 | 0.0% | 0.00% | – |
Q3 2018 | $104,000 | +82.5% | 17,200 | +59.3% | 0.00% | – |
Q2 2018 | $57,000 | -13.6% | 10,800 | -55.6% | 0.00% | – |
Q1 2017 | $66,000 | -5.7% | 24,300 | 0.0% | 0.00% | – |
Q4 2016 | $70,000 | -30.0% | 24,300 | 0.0% | 0.00% | – |
Q3 2016 | $100,000 | +20.5% | 24,300 | -7.3% | 0.00% | – |
Q2 2016 | $83,000 | – | 26,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 919,000 | $4,816,000 | 2.29% |
RTW INVESTMENTS, LP | 6,256,840 | $32,786,000 | 2.24% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $2,515,000 | 1.08% |
Bpifrance SA | 828,262 | $4,340,000 | 0.49% |
WS MANAGEMENT LLLP | 888,722 | $4,657,000 | 0.28% |
Eventide Asset Management | 1,146,580 | $6,008,000 | 0.21% |
683 Capital Management, LLC | 362,386 | $1,899,000 | 0.17% |
Orbimed Advisors | 1,243,200 | $6,514,000 | 0.10% |
Sofinnova Investments, Inc. | 159,237 | $835,000 | 0.08% |
Rhenman & Partners Asset Management AB | 119,673 | $627,000 | 0.07% |